Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adjuvants, Vaccine (Phase 1)
COVID-19 (Phase 3)
Diarrhea (Phase 3)
Epstein-Barr Virus Infections (Phase 1/Phase 2)
Fever (Phase 2/Phase 3)
Healthy Volunteers (Phase 2)
Hemorrhagic Fever, Ebola (Phase 1)
Herpesvirus 4, Human (Phase 1)
Infections (Phase 1/Phase 2)
Infectious Mononucleosis (Phase 1/Phase 2)
Influenza, Human (Phase 2)
Irritable Mood (Phase 2/Phase 3)
Malaria (Phase 3)
Malaria, Falciparum (Phase 4)
Malaria, Vivax (Phase 1/Phase 2)
Nausea (Phase 2/Phase 3)
Parasitic Diseases (Phase 1/Phase 2)
Plasmodium falciparum (Early Phase 1)
Protozoan Infections (Phase 1)
Respiratory Syncytial Viruses (Phase 2)
Rotavirus Infections (Phase 3)
Severe Acute Respiratory Syndrome (Phase 3)
Vector Borne Diseases (Phase 1/Phase 2)
Vomiting (Phase 2/Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue